Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin

Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin

US Patent 6239124 · Granted May 29, 2001

Estimated economic value: $6,940,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions of glycopyrronium salt for inhalation2019
Spontaneously dispersible N-benzoyl staurosporine compositions2014
Pharmaceutical compositions comprising colloidal silicon dioxide2013
Spontaneously dispersible N-benzoyl staurosporine compositions2013
Combinations of immunosuppressive agents for the treatment or prevention of graf2013
2,4-diaminopyrimidine derivatives2013
2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors2012
2,4-diaminopyrimidine derivatives2011
Indolylmaleimide derivatives2010
Indolylmaleimide derivatives2010
2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitor2010
Indolylmaleimide derivatives2009